
IRTC · NASDAQ
iRhythm Technologies, Inc.
$115.00 -18.91 (-14.12%)
Company overview
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, wearable biosensor with a cloud-based data analytics platform to help physicians monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors are single-use, wire-free, wearable patch-based biosensors that record patients' heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $3.8B
- Employees
- 2,000
- Headquarters
- San Francisco, CA
- Website
- irhythmtech.com
- CEO
- Quentin S. Blackford
- Listed
- October 20, 2016
- P/E
- -136.63
- Dividend yield
- 0.00%
Company financials
- Revenue
- $788M
- Gross profit
- $559M
- Operating income
- -$21.6M
- EBITDA
- $4.8M
- Net income
- -$27.8M
- EPS
- -$0.86
- Total assets
- $1B
- Total debt
- $729M
- Gross margin
- 71.00%
- Net margin
- -3.53%
- Earnings yield
- -0.73%
No geographic segmentation.
Showing FY 2025
News